Segulah ups stake in Kemetyl

Segulah III acquired a 50% stake in Kemetyl from Pemco in February 2007 and has now acquired the remaining shares from its co-owner.

Segulah previously owned CCS between 2003 and 2005, then reacquired the company and Opus in May 2011 and merged them into CCS/Opus, held by Segulah IV.

Following the current transaction, CCS/Opus will take over Kemetyl's subsidiary health business Antibac. The changes allow Segulah to consolidate its hygiene businesses, while leaving Kemetyl to focus on car care, home and garden, and industrial chemicals.

Company
Kemetyl is a car care product and chemicals supplier, founded in 1918. Following the divestment of Antibac it will focus on its European operations in car care, home and garden, and industrial chemicals.

Antibac encompasses a range of alcohol-based disinfectants developed by Kemetyl for professional and consumer use.

CCS/Opus arose from a merger between CCS and Opus. Previous to the merger, CCS supplied personal care products (including skin and dental care) primarily to pharmacies in Scandinavia and the UK, whereas Opus supplied disinfectants and skin care products to Scandinavian hospitals and office supply wholesalers.

People
Christian Tegenmark, investment manager, and Christian Sievert, managing partner, worked on the deal for Segulah.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Expansion
• Industrials
• Consumer
• Segulah
• Sweden